Immunic is trading at $7.76, up 9.33% in pre-market, with biotech-sector strength offering supportive context but no confirmed company-specific catalyst.
- No new Immunic announcement was listed for October 16; its latest releases were dated October 13 and October 7.
- XBI rose 2.05% on October 15 and was up 0.71% pre-market on October 16.
- No pre-market volume figure was verified.